Aseptuva

Bern, Switzerland Founded: 2021 • Age: 5 yrs
In-situ disinfection technology for preventing hospital infections is developed.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Aseptuva

Aseptuva is a company based in Bern (Switzerland) founded in 2021 by Henry Twerenbold. Aseptuva offers products and services including Disinfection Adaptors. Aseptuva operates in a competitive market with competitors including Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.

  • Headquarter Bern, Switzerland
  • Founders Henry Twerenbold
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aseptuva

Aseptuva offers a comprehensive portfolio of products and services, including Disinfection Adaptors.

Product name locked
Category locked
Primary

Automated adaptors using Far-UVC to prevent bacterial infections at entry sites.

Funding Insights of Aseptuva

Investors in Aseptuva

Aseptuva has secured backing from 2 investors. Prominent investors backing the company include Convert2Green and MedPhab.

All
Investor Description Founded Year Domain Location
Convert2Green is focused on accelerating SME innovations in Europe.
Locked Locked Locked
MedPhab is focused on photonics-based medical diagnostics development.
Locked Locked Locked
Premium access

Investor details for Aseptuva

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aseptuva

Investments
Premium access

Investment portfolio details for Aseptuva

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aseptuva

Premium access

Detailed financials for Aseptuva

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aseptuva Comparisons

Aseptuva Primary company
Description
In-situ disinfection technology for preventing hospital infe...
Location
Bern, Switzerland
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Aseptuva

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aseptuva

Aseptuva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of healthcare consulting services
Locked Locked Locked
Medical insurance services for patients and employees are provided.
Locked Locked Locked
Business support and supply chain management services are offered.
Locked Locked Locked
Advisory services are offered to U.S. healthcare providers.
Locked Locked Locked
Provider of comprehensive sterilization solutions and expert consulting services
Locked Locked Locked
Contract manufacturing is provided for life sciences and diagnostics reagents.
Premium access

Detailed competitors of Aseptuva

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aseptuva

Premium access

Complete news archive for Aseptuva

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aseptuva

Aseptuva was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Aseptuva is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.

Henry Twerenbold is the current CEO of Aseptuva. They have also founded this company.

Aseptuva was founded in 2021 in Bern, Switzerland, within the medtech sector. Automated plug-and-play disinfection adaptors based on Far-UVC technology are provided by the company to address pathogenic colonization around catheters. Operations focus on in-situ solutions for reducing hospital-acquired infections, with deployment targeted at healthcare settings. The technology integrates directly into medical devices for ongoing pathogen control.

Aseptuva's top competitors include Qualicorp, Heartland Dental and Argonautms.

Aseptuva offers Disinfection Adaptors.

Aseptuva has 2 investors. Key investors include Convert2Green, and MedPhab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available